Dombkowski Ashley L. 4

What Happened
Ashley L. Dombkowski, a director of RAPT Therapeutics, was granted 4,956 restricted stock units (RSUs) on January 30, 2026. The RSUs were issued at $0.00 (no cash exchanged) and represent a contingent right to receive one share of common stock per RSU upon vesting. This is an annual non-employee director equity award — not a purchase or sale.

Key Details

• Transaction date: 2026-01-30; reported on Form 4 filed 2026-02-02.
• Grant: 4,956 RSUs; reported acquisition price $0.00 (total $0 at grant).
• Vesting: Per filing footnote, the RSUs fully vest on the first anniversary of the grant (Jan 30, 2027). Each RSU converts to one share upon vesting.
• Shares owned after transaction: not specified in the filing.
• Filing timeliness: Form 4 filed within the typical two-business-day window (appears timely).

Context
RSU grants to non-employee directors are routine compensation and do not reflect an immediate market buy or sell. Because these units only convert to actual shares if and when they vest, they are a deferred form of compensation rather than an immediate change in outstanding shares.